Going Back to a New Approach: FDA, Outside Experts, and Conflicts of Interest

FDA has gone far-maybe too far-in excluding outside experts from advisory committee panels who have potential conflicts of interest. The agency is considering easing back the restrictions. What will it mean for future external guidance to FDA?